tenk.fyi

Editas Medicine, Inc.

EDITNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$40.5M

25.4% YoY

Net Income

-$160.1M

32.5% YoY

EPS

$-1.80

37.5% YoY

Cash

$146.6M

11.5% YoY

FY 2025 · As of 2025-12-31